Related Experiment Videos
Epidermal growth factor receptor and lipid membrane components in human lung cancers
A Di Carlo1, A Mariano, P E Macchia
1Centro di Endocrinologia ed Oncologia Sperimentale del CNR, II Facoltà di Medicina e Chirurgia, Università di Napoli, Italy.
Journal of Endocrinological Investigation
|February 1, 1993
Summary
Human lung tumors often show increased epidermal growth factor (EGF) receptor levels. The highest EGF receptor levels were found in poorly differentiated squamous cell carcinomas, with no correlation to tumor stage.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Epidermal Growth Factor (EGF) plays a crucial role in cell growth and is often implicated in cancer development.
- Elevated levels of EGF receptors (EGF-R) have been observed in various human cancers, suggesting their involvement in tumorigenesis.
- Understanding EGF-R expression in lung cancer subtypes is vital for potential therapeutic strategies.
Purpose of the Study:
- To quantify the binding of 125I-epidermal growth factor (EGF) to plasma membranes of human lung tumors.
- To investigate the correlation between EGF receptor levels and clinical parameters like tumor stage and differentiation.
- To analyze the alterations in ganglioside and phospholipid profiles in relation to EGF receptor expression.
Main Methods:
- Quantification of 125I-EGF binding to plasma membranes from 54 human lung tumors (34 squamous cell carcinomas, 20 adenocarcinomas) and 20 normal lung tissues.
- Assessment of EGF receptor (EGF-R) levels by measuring 125I-EGF binding.
- Analysis of ganglioside and phospholipid content and distribution in individual tumor samples.
- Comparison of EGF-R binding with clinical staging and tumor differentiation grades.
Main Results:
- Most lung tumor samples exhibited higher EGF receptor levels compared to normal lung tissue.
- A moderate increase (2-5 fold) in 125I-EGF binding was observed in the majority of tumors; a significant increase (>10 fold) was rare (5-10%).
- No correlation was found between tumor stage and 125I-EGF binding. However, poorly differentiated squamous cell carcinomas showed the highest EGF-R levels.
- Specific changes in gangliosides (decreased GD1b, GD1a; increased GM1, GM3) and phospholipids were noted, but showed no correlation with EGF-R binding levels.
Conclusions:
- Human lung tumors frequently overexpress EGF receptors, with varying degrees of elevation.
- Poorly differentiated squamous cell carcinomas are associated with the highest EGF receptor expression.
- Alterations in specific gangliosides and phospholipids occur in lung tumors but do not directly correlate with EGF receptor binding levels in this study.